Longeveron Future Growth
Future criteria checks 2/6
Longeveron is forecast to grow earnings and revenue by 23.9% and 60.8% per annum respectively while EPS is expected to grow by 58% per annum.
Key information
23.9%
Earnings growth rate
58.0%
EPS growth rate
Biotechs earnings growth | 24.0% |
Revenue growth rate | 60.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 29 Apr 2024 |
Recent future growth updates
Recent updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17Longeveron Inc.: A New Approach To Treat Alzheimer's
Oct 09Longeveron spikes after FDA’s Fast Track Designation for lead candidate
Aug 31Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Longeveron rises ~20%, co to present Alzheimer's trial abstract at leading conference
Jul 07Longeveron: Small-Cap Biotech Targeting Large Alzheimer's Market
May 06Companies Like Longeveron (NASDAQ:LGVN) Are In A Position To Invest In Growth
Apr 03Longeveron: Speculative Biotech Worth A Look On Rare Disease, Aging, And Alzheimer's Focuses
Feb 15Longeveron: Spooky Social-Media Generated Spike Signifies Nothing
Nov 29Is Longeveron (NASDAQ:LGVN) In A Good Position To Deliver On Growth Plans?
Nov 20Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -32 | -12 | N/A | 1 |
12/31/2025 | 0 | -25 | -16 | N/A | 3 |
12/31/2024 | 0 | -23 | -22 | -17 | 3 |
12/31/2023 | 1 | -22 | -20 | -19 | N/A |
9/30/2023 | 1 | -21 | -18 | -17 | N/A |
6/30/2023 | 1 | -20 | -18 | -17 | N/A |
3/31/2023 | 1 | -20 | -17 | -16 | N/A |
12/31/2022 | 1 | -19 | -15 | -14 | N/A |
9/30/2022 | 1 | -18 | -15 | -13 | N/A |
6/30/2022 | 1 | -18 | -12 | -11 | N/A |
3/31/2022 | 1 | -17 | -12 | -11 | N/A |
12/31/2021 | 1 | -17 | -11 | -10 | N/A |
9/30/2021 | 2 | -14 | -9 | -9 | N/A |
6/30/2021 | 4 | -10 | -7 | -7 | N/A |
3/31/2021 | 4 | -7 | -5 | -5 | N/A |
12/31/2020 | 6 | -4 | -3 | -2 | N/A |
9/30/2020 | 6 | -3 | -2 | -2 | N/A |
12/31/2019 | 6 | -3 | -3 | -2 | N/A |
12/31/2018 | 2 | -6 | -5 | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LGVN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LGVN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LGVN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LGVN's revenue (60.8% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: LGVN's revenue (60.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LGVN's Return on Equity is forecast to be high in 3 years time